Markets

Kwality Wall's shares trade 30% lower vs discovered price: buy or avoid?

Kwality Wall's shares listed at a sharp discount on NSE and BSE, falling up to 30% from discovered price. Analysts flag margin pressure, seasonality risks, and valuation concerns

Stock Market Close: Sensex gains 317 pts; Nifty tops 25,500 despite US-Iran tensions; SMIDs mixed

Sensex Today | Stock Market Highlights, Friday, Feb 20: In the broader markets, the Nifty MidCap 100 ended 0.48 per cent higher, while Nifty Smallcap was down 0.11 per cent

IPO Calendar: Clean Max Enviro, Omnitech to open; 3 SME listings lined up

IPO Calendar for Next Week: Gaudium IVF is slated to close its issue on February 24 and list on the bourses on February 27, 2026

BSE share price erases early gains, falls 1% on report of market share loss

BSE share price declined 1.04 per cent to the day's low of ₹2,713.30 on the National Stock Exchange (NSE)

Dee Development shares zoom 10% after $40-million order win from US firm

Dee Development shares: Dee Development posted a net profit of ₹18.28 crore for the quarter ended December 2025, compared with a net loss of ₹13.33 crore in the corresponding quarter last year

Dividend, bonus, stock split: NBCC, Angel One, 6 others to track next week

Here is the complete list of companies that will remain in focus next week following announcements of corporate actions such as dividend payouts, bonus issues, and stock splits of equity shares

FirstCry shares surge 17% from record low; snap four-day losing streak

Brainbees Solutions share price touched a record low of ₹207.05 on the National Stock Exchange (NSE) on Thursday

5paisa Capital jumps 9% as board to consider fundraising on Feb 24

In a year, 5paisa Capital shares have slipped around 15 per cent as compared to Sensex's rise of 8.9 per cent

EMS sector at risk amid memory price surge; CLSA cuts Dixon Tech to Hold

CLSA downgraded Dixon Technologies to 'Hold' from 'Outperform', cutting its target price to ₹12,100 from ₹15,880 per share

Paras Defence shares rise 4% as it acquires 49% stake in Himanshi Thermal

Paras Defence and Space Technologies share price rose 4.4 per cent to ₹658 in the intraday trade on the National Stock Exchange (NSE)

Nifty Pharma eyes breakout; Biocon, 2 others may rally up to 22%: Analyst

Kunal Shah of Mirae Asset ShareKhan expects breakout on the Nifty Pharma index above 23,500 levels; the analyst recommends Lupin, Biocon and Torrent Pharma as top sectoral stock bets.

Institutional investors tilt to financials; capex sectors in focus: Antique

In January 2026, mutual funds increased their exposure to domestic sectors such as services, cement, real estate, consumer services, financial services, and power & utilities

Axis says V-Mart Retail to benefit from rural recovery; predicts 31% upside

Axis Direct said that V-Mart is well-placed to benefit from rural recovery and market share gains from unorganised players

Novartis shares hit 20% upper circuit as Swiss parent to sell entire stake

Novartis AG has agreed to sell 17.4 million fully paid-up equity shares, representing 70.68 per cent equity of Novartis India, to a consortium

Geopolitics, muted earnings growth worrying markets: Sunny Agarwal

Sunny Agarwal of SBI Securities said that going ahead, the financial services sector will lead, which includes banks, both public sector (PSU) and private

LIC MF launches Technology Fund; SIP starts from ₹100: Who should invest?

LIC MF Technology Fund is a thematic equity scheme designed to provide comprehensive exposure to India's expanding technology landscape

Axis Sec sees upside in pharma, hospitals; Lupin, Aurobindo among top bets

Axis Securities has named Lupin, Aurobindo Pharma, Max, and Fortis as top picks, citing strong fundamentals, resilient growth drivers, and robust operational execution

ABB India shares jump 5% after Q3 results beat street's estimates

ABB India's revenue from operations rose 5.7 per cent to ₹3,557.01 crore, compared with ₹3,364.93 crore in the corresponding quarter last year

Turnaround ahead? Emkay Global upgrades IndusInd Bank to Buy, raises target

Emkay Global upgrades IndusInd Bank to Buy and raises target price to ₹1,100, citing leadership change, earnings recovery, RoA improvement, and asset quality moderation

Sundaram Finance, HSCL, VTL form 'Golden Cross' on charts; what lies ahead?

Hitesh Tailor, technical analyst at Choice Broking predicts up to 11 per cent upside for Sundaram Finance, HSCL and VTL following the 'Golden Crossover' and bullish set-up on the charts.